Physician profile
Mark Reed
NPI 1891771713
$1,903.48
in general payments reported to CMS, 2019-2025
10 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,017 · 2020: $25.22 · 2021: $14.18 · 2022: $152 · 2023: $309 · 2024: $251 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,000.06 | 2019-2025 | Precision Mis Bunion |
| Smith+Nephew, INC. | $279.97 | 2023-2024 | Pico, Oasis, Grafix Pl |
| Stryker Corporation | $152.15 | 2022 | |
| Organogenesis INC. | $123.64 | 2023 | Puraply |
| Integra Lifesciences Corporation | $118.89 | 2019 | |
| Ucb, INC. | $101.46 | 2024 | Fintepla |
| Misonix INC | $57.92 | 2019-2021 | |
| Medical Device Business Services, INC. | $40.26 | 2023 | |
| Viiv Healthcare Company | $15.12 | 2024 | Dovato |
| Merck Sharp & Dohme LLC | $14.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.